DENVER--(BUSINESS WIRE)--Assure Holdings Corp. (“Assure” or the “Company”) (OTC: IONM), today announced that it has amended the Convertible Note Exchange Offer of June 21, 2024, relating to the Company's 9% Convertible Debentures due in 2023 and 2024 (the “Assure Convertible Debentures”). This ninth amendment further amends and restates certain sections of the Convertible Note Exchange Offer (“Amended Offer Letter”) as follows: (i) updates the Amended Offer Letter to reflect a change in the con.

DENVER, July 22, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (“Assure” or the “Company”) (NASDAQ: IONM), today announced that it has extended the expiration date of its exchange offer (the “Offer”) relating to the Company's 9% Convertible Debentures due 2023 and 2024 (the “Assure Convertible Debentures”). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on July 26, 2024 (the “Expiration Date”) unless further extended.

DENVER, July 03, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it will effect a reverse stock split (the “Reverse Stock Split”) of its shares of common stock, $0.001 par value, at a ratio of 18 (old) for 1 (new) that will become effective on July 9, 2024 at 12:01 a.m. Pacific Standard Time.

Assure (NASDAQ: IONM ) stock is soaring higher on Thursday after the neuromonitoring surgical support services company withdrew a share offering. Assure notes that it no longer plans to move forward with a proposed stock offering that was announced on May 3.

Assure (NASDAQ: IONM ) stock is taking a beating on Thursday after the intraoperative neuromonitoring surgical support services company terminated a merger agreement with Danam Health. Assure was planning to merge a subsidiary with Danam Health.

DENVER, May 28, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that as a result of the delinquency in the timely filing of the Company's quarterly report on Form 10-Q for the period ended March 31, 2024 (the “10-Q”), the Company is out of compliance with Nasdaq Listing Rules (Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission) and that the Nasdaq Hearings Panel (the “Panel”) will consider this matter as an additional deficiency, under Listing Rule 5810(d), in their decision regarding the Company's continued listing on The Nasdaq Capital Market. Nasdaq's extension notice has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Capital Market.

DENVER, May 17, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that management has rescheduled the joint corporate update call with Danam for Wednesday, May 22, 2024 at 4:00 PM Eastern Time. Conference Call Information Date: Wednesday, May 22, 2024Time: 4:00 PM Eastern TimeToll Free: 1-877-545-0523International: 1-973-528-0016Participant Access Code: 229289Webcast Link: https://www.webcaster4.com/Webcast/Page/2566/50637 Conference Call Replay Information Toll Free:   1-877-481-4010International: 1-919-882-2331Replay Passcode: 50637Webcast Replay: https://www.webcaster4.com/Webcast/Page/2566/50637 About Assure Holdings Assure Holdings Corp. is a provider of outsourced intraoperative neuromonitoring and remote neurology services.

DENVER, May 16, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today it received a written notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that it has granted the Company an extension to regain compliance with the continued listing requirements for The Nasdaq Capital Market (the “Panel Decision”). The Hearings Panel granted the Company an extension until July 22, 2024, by which date the Company will be required to demonstrate compliance with all applicable initial listing requirements for the Nasdaq Capital Market in relation to its completion of its previously announced transaction with Danam Health Inc.

DENVER, May 16, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that at its adjourned Special Shareholder Meeting held on May 14, 2024, shareholders approved the proposal to amend the Company's Articles of Incorporation, to increase the number of authorized shares of common stock of the Company from 9,000,000 to 250,000,000. The Company intends to file the amendment to the Articles of Incorporation promptly to effect the increase in authorized common stock as soon as possible.

DENVER, May 15, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that the joint corporate update call with Danam scheduled for Thursday, May 16, 2024 at 4 p.m. Eastern Time has been postponed.